KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Return on Equity (2016 - 2025)

Historic Return on Equity for Dynavax Technologies (DVAX) over the last 15 years, with Q3 2025 value amounting to 0.08%.

  • Dynavax Technologies' Return on Equity fell 1200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.04% for FY2024, which is 600.0% up from last year.
  • Per Dynavax Technologies' latest filing, its Return on Equity stood at 0.08% for Q3 2025, which was down 1200.0% from 0.1% recorded in Q2 2025.
  • Dynavax Technologies' Return on Equity's 5-year high stood at 0.7% during Q3 2022, with a 5-year trough of 0.49% in Q1 2021.
  • In the last 5 years, Dynavax Technologies' Return on Equity had a median value of 0.03% in 2024 and averaged 0.14%.
  • Its Return on Equity has fluctuated over the past 5 years, first skyrocketed by 126400bps in 2021, then crashed by -6000bps in 2023.
  • Quarter analysis of 5 years shows Dynavax Technologies' Return on Equity stood at 0.69% in 2021, then fell by -21bps to 0.54% in 2022, then crashed by -102bps to 0.01% in 2023, then skyrocketed by 509bps to 0.04% in 2024, then crashed by -297bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.1% for Q2 2025, and 0.11% during Q1 2025.